查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1842259

全球抗體生產市場：市場規模、佔有率和趨勢分析（按產品、類型、製程、最終用途和地區分類），細分市場預測（2025-2033 年）

Antibody Production Market Size, Share & Trends Analysis Report By Product (Instruments, Consumables, Software), By Type (Polyclonal Antibody, Monoclonal Antibody), By Process, By End Use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 180 Pages | 商品交期: 2-10個工作天內

價格

抗體生產：市場概覽

2024年全球抗體製造市場規模預計為154.4億美元，預計到2033年將達到398億美元，2025年至2033年的複合年成長率為11.2%。

癌症、糖尿病和心血管疾病等慢性疾病的日益普遍，以及對治療性抗體的需求不斷成長，正在推動抗體生產市場的蓬勃發展。

個人化抗體和新一代抗體

全球抗體生產市場正經歷顯著的變革，從傳統的單株抗體轉型為更複雜的新一代抗體類型。雙特異性抗體、抗體藥物複合體（ADC）和工程化單株抗體正成為標靶治療疾病的重要工具，能夠更精準、更有效率地治療疾病，而個人化治療也日益成為標準療法。這些新治療方法不僅改善了治療效果，也為生物製藥公司在競爭日益激烈的市場環境中實現產品組合差異化提供了新的機會。

新一代抗體的興起刺激了先進、專業化生產技術的需求。與依賴相對標準化生產過程的傳統單株抗體不同，雙特異性抗體和抗體偶聯藥物（ADC）需要更複雜的細胞株開發、純化技術和偶聯平台。為了滿足這些不斷變化的需求，製造商正在迅速採用創新解決方案，例如高密度灌註生物反應器、模組化一次性系統和整合式連續生物製程。這些技術進步對於在維持複雜生技藥品所需的高品質和安全標準的同時，實現經濟高效的規模化生產至關重要。

強勁的投資熱潮進一步推動了市場成長，既有成熟的製藥公司，也有希望利用新一代抗體線的新興生物技術公司。全球範圍內的夥伴關係、收購和產能擴張都在加速進行，尤其是在那些大力投資生物製藥基礎設施的地區。隨著法律規範的不斷改進以適應這些創新治療方法，那些擁有滿足個人化和新一代抗體獨特需求的生產能力的公司，將更有利於在不斷擴大的市場中佔據更大的佔有率。最終，科學創新、卓越製造和策略投資的融合正在重塑抗體製造格局，並維持其長期強勁成長。

目錄

第1章 分析方法和範圍

第2章執行摘要

第3章：抗體生產市場：影響因素與趨勢

  • 市場關聯性展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素的影響分析
    • 市場限制因素的影響分析
  • 產業分析工具
    • PESTEL 分析
    • 波特五力分析

第4章：抗體生產市場：依產品分類的估算與趨勢分析

  • 細分儀表板
  • 全球抗體生產市場：按產品分類的波動分析
  • 全球抗體生產市場規模及產品趨勢分析（2021-2033）
  • 裝置
    • 生物反應器
    • 層析法系統
    • 過濾系統
  • 消耗品
    • 媒體
    • 緩衝液和試劑
    • 層析法樹脂和色譜管柱
    • 過濾耗材及配件
    • 其他
  • 軟體

第5章：抗體生產市場：依製程分類的估算與趨勢分析

  • 細分儀表板
  • 全球抗體生產市場：按製程分類的變化分析
  • 全球抗體生產市場規模及趨勢分析（依製程分類）（2021-2033 年）
  • 上游加工
  • 下游加工

第6章：抗體生產市場：按類型分類的估算與趨勢分析

  • 細分儀表板
  • 全球抗體生產市場：波動分析：按類型分類
  • 全球抗體生產市場規模及趨勢分析（按類型分類）（2021-2033年）
  • 單株抗體
  • 多株抗體

第7章：抗體生產市場：依最終用途分類的估算與趨勢分析

  • 細分儀表板
  • 全球抗體生產市場：依最終用途分類的波動分析
  • 全球抗體生產市場規模及趨勢分析（按最終用途分類）（2021-2033 年）
  • 製藥和生物技術公司
  • 考場
  • CRO/CDMO

第8章：抗體生產市場：區域估算與趨勢分析

  • 抗體生產市場：區域展望
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第9章 競爭情勢

  • 公司分類
  • 策略規劃
  • 企業市場分析（2024）
  • 公司簡介/上市公司
    • Lonza Group
    • Thermo Fisher Scientific, Inc.
    • AGC Biologics
    • Wuxi Biologics
    • Charles River Laboratories
    • Biointron
    • Danaher
    • Sartorius
    • Eppendorf
    • Merck KGaA
Product Code: GVR-1-68038-698-1

Antibody Production Market Summary

The global antibody production market size was estimated at USD 15.44 billion in 2024 and is projected to reach USD 39.80 billion by 2033, growing at a CAGR of 11.2% from 2025 to 2033. Increasing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular diseases, coupled with the growing demand for therapeutic antibodies, has led to the rapid growth of the antibody production market.

Personalized and Next-Generation Antibodies

The global antibody production market is experiencing a significant shift as the industry moves beyond conventional monoclonal antibodies toward more complex, next-generation formats. Personalized therapies are increasingly becoming the standard of care, with bispecific antibodies, antibody-drug conjugates (ADCs), and engineered monoclonal antibodies emerging as critical tools in targeting diseases with greater precision and efficacy. These novel modalities not only enhance therapeutic outcomes but also open new opportunities for biopharmaceutical companies to differentiate their portfolios in an increasingly competitive landscape.

The rise of next-generation antibodies is fueling demand for advanced and highly specialized production technologies. Unlike traditional mAbs, which rely on relatively standardized production processes, bispecifics and ADCs require more sophisticated cell line development, purification techniques, and conjugation platforms. Manufacturers are rapidly adopting innovative solutions such as high-density perfusion bioreactors, modular single-use systems, and integrated continuous bioprocessing to meet these evolving requirements. This technological advancement is essential to achieve cost-effective scalability while maintaining the high quality and safety standards expected for complex biologics.

Market growth is further reinforced by strong investment flows from both established pharmaceutical players and emerging biotech firms aiming to capitalize on next-generation antibody pipelines. Partnerships, acquisitions, and capacity expansion initiatives are accelerating globally, with a particular focus on regions that are investing heavily in biopharma infrastructure. As regulatory frameworks evolve to accommodate these innovative therapies, companies that can align their production capabilities with the unique demands of personalized and next-generation antibodies are well positioned to capture a larger share of this expanding market. Ultimately, the convergence of scientific innovation, manufacturing excellence, and strategic investment is reshaping the antibody production landscape and sustaining robust long-term growth.

Global Antibody Production Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global antibody production market based on product, process, type, end use, and region.

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Instruments
    • Bioreactors
    • Multi-use Bioreactors
    • Single-use bioreactors
    • Chromatography systems
    • Filtration systems
  • Consumables
    • Media
    • Buffers and reagents
    • Chromatography resins and columns
    • Filtration consumables and accessories
    • Others
    • Software
  • Process Outlook (Revenue, USD Million, 2021 - 2033)
  • Upstream Processing
  • Downstream Processing
  • Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Monoclonal Antibody
  • Polyclonal Antibody
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Pharmaceutical and biotechnology companies
  • Research laboratories
  • CROs and CDMOs
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Segment Definitions
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Objective
    • 1.4.1. Objective 1
    • 1.4.2. Objective2
    • 1.4.3. Objective 3
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary Research
  • 1.7. Information or Data Analysis:
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
  • 1.10. List of Secondary Sources
  • 1.11. List of Abbreviations

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Antibody Production Market Variables and Trends

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Impact Analysis
      • 3.2.1.1. Increased demand for therapeutic antibodies
      • 3.2.1.2. Increasing investment in R&D
      • 3.2.1.3. Rise in adoption of antibody production for personalized medicine and companion diagnostics
    • 3.2.2. Market Restraint Impact Analysis
      • 3.2.2.1. Stringent government regulations
  • 3.3. Industry Analysis Tools
    • 3.3.1. PESTEL Analysis
    • 3.3.2. Porter's Five Forces Analysis

Chapter 4. Antibody Production Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Antibody Production Market Product Movement Analysis
  • 4.3. Global Antibody Production Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
  • 4.4. Instruments
    • 4.4.1. Global Instruments Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.2. Bioreactors
      • 4.4.2.1. Global Bioreactors Market Estimates and Forecasts, 2021 - 2033 (USD Millions)
      • 4.4.2.2. Multi-use Bioreactor
        • 4.4.2.2.1. Global Multi-Use Bioreactors Market Estimates and Forecasts, 2021 - 2033 (USD Millions)
      • 4.4.2.3. Single-use Bioreactor
        • 4.4.2.3.1. Global Single-Use Bioreactors Market Estimates and Forecasts, 2021 - 2033 (USD Millions)
    • 4.4.3. Chromatography Systems
      • 4.4.3.1. Global Chromatography Systems Market Estimates and Forecasts, 2021 - 2033 (USD Millions)
    • 4.4.4. Filtration Systems
      • 4.4.4.1. Global Filtration Systems Market Estimates and Forecasts, 2021 - 2033 (USD Millions)
  • 4.5. Consumables
    • 4.5.1. Global Consumables Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.2. Media
      • 4.5.2.1. Global Media Market Estimates and Forecasts, 2021 - 2033 (USD Millions)
    • 4.5.3. Buffers and Reagents
      • 4.5.3.1. Global Buffers and Reagents Market Estimates and Forecasts, 2021 - 2033 (USD Millions)
    • 4.5.4. Chromatography Resins and Columns
      • 4.5.4.1. Global Chromatography Resins and Columns Market Estimates and Forecasts, 2021 - 2033 (USD Millions)
    • 4.5.5. Filtration Consumables and Accessories
      • 4.5.5.1. Global Filtration Consumables and Accessories Market Estimates and Forecasts, 2021 - 2033 (USD Millions)
    • 4.5.6. Others
      • 4.5.6.1. Global Others Market Estimates and Forecasts, 2021 - 2033 (USD Millions)
  • 4.6. Software
    • 4.6.1. Global Software Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Antibody Production Market: Process Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Antibody Production Market Process Movement Analysis
  • 5.3. Global Antibody Production Market Size & Trend Analysis, by Process, 2021 to 2033 (USD Million)
  • 5.4. Upstream Processing
    • 5.4.1. Global Upstream Processing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Downstream Processing
    • 5.5.1. Global Downstream Processing Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Antibody Production Market: Type Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Antibody Production Market Type Movement Analysis
  • 6.3. Global Antibody Production Market Size & Trend Analysis, by Type, 2021 to 2033 (USD Million)
  • 6.4. Monoclonal Antibody
    • 6.4.1. Global Monoclonal Antibody Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Polyclonal Antibody
    • 6.5.1. Global Polyclonal Antibody Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Antibody Production Market: End Use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Global Antibody Production Market End Use Movement Analysis
  • 7.3. Global Antibody Production Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 7.4. Pharmaceutical and Biotechnology Companies
    • 7.4.1. Global Pharmaceutical and Biotechnology Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Research Laboratories
    • 7.5.1. Global Research Laboratories Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. CROs and CDMOs
    • 7.6.1. Global CROs and CDMOs Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Antibody Production Market: Regional Estimates & Trend Analysis

  • 8.1. Antibody Production Market: Region Outlook
  • 8.2. North America
    • 8.2.1. North America Antibody Production Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.2.2. U.S.
      • 8.2.2.1. Key Country Dynamics
      • 8.2.2.2. Competitive Scenario
      • 8.2.2.3. Regulatory Scenario
      • 8.2.2.4. U.S. Antibody Production Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.2.3. Canada
      • 8.2.3.1. Key Country Dynamics
      • 8.2.3.2. Competitive Scenario
      • 8.2.3.3. Regulatory Scenario
      • 8.2.3.4. Canada Antibody Production Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.2.4. Mexico
      • 8.2.4.1. Key Country Dynamics
      • 8.2.4.2. Competitive Scenario
      • 8.2.4.3. Regulatory Scenario
      • 8.2.4.4. Mexico Antibody Production Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.3. Europe
    • 8.3.1. Europe Antibody Production Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.3.2. UK
      • 8.3.2.1. Key Country Dynamics
      • 8.3.2.2. Competitive Scenario
      • 8.3.2.3. Regulatory Scenario
      • 8.3.2.4. UK Antibody Production Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.3.3. Germany
      • 8.3.3.1. Key Country Dynamics
      • 8.3.3.2. Competitive Scenario
      • 8.3.3.3. Regulatory Scenario
      • 8.3.3.4. Germany Antibody Production Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.3.4. France
      • 8.3.4.1. Key Country Dynamics
      • 8.3.4.2. Competitive Scenario
      • 8.3.4.3. Regulatory Scenario
      • 8.3.4.4. France Antibody Production Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.3.5. Italy
      • 8.3.5.1. Key Country Dynamics
      • 8.3.5.2. Competitive Scenario
      • 8.3.5.3. Regulatory Scenario
      • 8.3.5.4. Italy Antibody Production Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.3.6. Spain
      • 8.3.6.1. Key Country Dynamics
      • 8.3.6.2. Competitive Scenario
      • 8.3.6.3. Regulatory Scenario
      • 8.3.6.4. Spain Antibody Production Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.3.7. Denmark
      • 8.3.7.1. Key Country Dynamics
      • 8.3.7.2. Competitive Scenario
      • 8.3.7.3. Regulatory Scenario
      • 8.3.7.4. Denmark Antibody Production Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.3.8. Sweden
      • 8.3.8.1. Key Country Dynamics
      • 8.3.8.2. Competitive Scenario
      • 8.3.8.3. Regulatory Scenario
      • 8.3.8.4. Sweden Antibody Production Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.3.9. Norway
      • 8.3.9.1. Key Country Dynamics
      • 8.3.9.2. Competitive Scenario
      • 8.3.9.3. Regulatory Scenario
      • 8.3.9.4. Norway Antibody Production Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.4. Asia Pacific
    • 8.4.1. Asia Pacific Antibody Production Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.4.2. China
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Competitive Scenario
      • 8.4.2.3. Regulatory Scenario
      • 8.4.2.4. China Antibody Production Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.4.3. Japan
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Competitive Scenario
      • 8.4.3.3. Regulatory Scenario
      • 8.4.3.4. Japan Antibody Production Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.4.4. India
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Competitive Scenario
      • 8.4.4.3. Regulatory Scenario
      • 8.4.4.4. India Antibody Production Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.4.5. South Korea
      • 8.4.5.1. Key Country Dynamics
      • 8.4.5.2. Competitive Scenario
      • 8.4.5.3. Regulatory Scenario
      • 8.4.5.4. South Korea Antibody Production Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.4.6. Australia
      • 8.4.6.1. Key Country Dynamics
      • 8.4.6.2. Competitive Scenario
      • 8.4.6.3. Regulatory Scenario
      • 8.4.6.4. Australia Antibody Production Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.4.7. Thailand
      • 8.4.7.1. Key Country Dynamics
      • 8.4.7.2. Competitive Scenario
      • 8.4.7.3. Regulatory Scenario
      • 8.4.7.4. Thailand Antibody Production Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.5. Latin America
    • 8.5.1. Latin America Antibody Production Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.5.2. Brazil
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Competitive Scenario
      • 8.5.2.3. Regulatory Scenario
      • 8.5.2.4. Brazil Antibody Production Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.5.3. Argentina
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Competitive Scenario
      • 8.5.3.3. Regulatory Scenario
      • 8.5.3.4. Argentina Antibody Production Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.6. MEA
    • 8.6.1. MEA Antibody Production Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.6.2. South Africa
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Competitive Scenario
      • 8.6.2.3. Regulatory Scenario
      • 8.6.2.4. South Africa Antibody Production Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.6.3. Saudi Arabia
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Competitive Scenario
      • 8.6.3.3. Regulatory Scenario
      • 8.6.3.4. Saudi Arabia Antibody Production Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.6.4. UAE
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Competitive Scenario
      • 8.6.4.3. Regulatory Scenario
      • 8.6.4.4. UAE Antibody Production Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.6.5. Kuwait
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Competitive Scenario
      • 8.6.5.3. Regulatory Scenario
      • 8.6.5.4. Kuwait Antibody Production Market Estimates And Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company Categorization
  • 9.2. Strategy Mapping
  • 9.3. Company Market Position Analysis, 2024
  • 9.4. Company Profiles/Listing
    • 9.4.1. Lonza Group
      • 9.4.1.1. Overview
      • 9.4.1.2. Financial Performance
      • 9.4.1.3. Product Benchmarking
      • 9.4.1.4. Strategic Initiatives
    • 9.4.2. Thermo Fisher Scientific, Inc.
      • 9.4.2.1. Overview
      • 9.4.2.2. Financial Performance
      • 9.4.2.3. Product Benchmarking
      • 9.4.2.4. Strategic Initiatives
    • 9.4.3. AGC Biologics
      • 9.4.3.1. Overview
      • 9.4.3.2. Financial Performance
      • 9.4.3.3. Product Benchmarking
      • 9.4.3.4. Strategic Initiatives
    • 9.4.4. Wuxi Biologics
      • 9.4.4.1. Overview
      • 9.4.4.2. Financial Performance
      • 9.4.4.3. Product Benchmarking
      • 9.4.4.4. Strategic Initiatives
    • 9.4.5. Charles River Laboratories
      • 9.4.5.1. Overview
      • 9.4.5.2. Financial Performance
      • 9.4.5.3. Product Benchmarking
      • 9.4.5.4. Strategic Initiatives
    • 9.4.6. Biointron
      • 9.4.6.1. Overview
      • 9.4.6.2. Financial Performance
      • 9.4.6.3. Product Benchmarking
      • 9.4.6.4. Strategic Initiatives
    • 9.4.7. Danaher
      • 9.4.7.1. Overview
      • 9.4.7.2. Financial Performance
      • 9.4.7.3. Product Benchmarking
      • 9.4.7.4. Strategic Initiatives
    • 9.4.8. Sartorius
      • 9.4.8.1. Overview
      • 9.4.8.2. Financial Performance
      • 9.4.8.3. Product Benchmarking
      • 9.4.8.4. Strategic Initiatives
    • 9.4.9. Eppendorf
      • 9.4.9.1. Overview
      • 9.4.9.2. Financial Performance
      • 9.4.9.3. Product Benchmarking
      • 9.4.9.4. Strategic Initiatives
    • 9.4.10. Merck KGaA
      • 9.4.10.1. Overview
      • 9.4.10.2. Financial Performance
      • 9.4.10.3. Product Benchmarking
      • 9.4.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 Global antibody production market, by product, 2021 - 2033 (USD Million)
  • Table 3 Global antibody production market, by process, 2021 - 2033 (USD Million)
  • Table 4 Global antibody production market, by type, 2021 - 2033 (USD Million)
  • Table 5 Global antibody production market, by end use, 2021 - 2033 (USD Million)
  • Table 6 Global antibody production market, by region, 2021 - 2033 (USD Million)
  • Table 7 North America antibody production market, by country, 2021 - 2033 (USD Million)
  • Table 8 North America antibody production market, by product, 2021 - 2033 (USD Million)
  • Table 9 North America antibody production market, by process, 2021 - 2033 (USD Million)
  • Table 10 North America antibody production market, by type, 2021 - 2033 (USD Million)
  • Table 11 North America antibody production market, by end use, 2021 - 2033 (USD Million)
  • Table 12 U.S. antibody production market, by product, 2021 - 2033 (USD Million)
  • Table 13 U.S. antibody production market, by process, 2021 - 2033 (USD Million)
  • Table 14 U.S. antibody production market, by type, 2021 - 2033 (USD Million)
  • Table 15 U.S. antibody production market, by end use, 2021 - 2033 (USD Million)
  • Table 16 Canada antibody production market, by product, 2021 - 2033 (USD Million)
  • Table 17 Canada antibody production market, by process, 2021 - 2033 (USD Million)
  • Table 18 Canada antibody production market, by type, 2021 - 2033 (USD Million)
  • Table 19 Canada antibody production market, by end use, 2021 - 2033 (USD Million)
  • Table 20 Mexico antibody production market, by product, 2021 - 2033 (USD Million)
  • Table 21 Mexico antibody production market, by process, 2021 - 2033 (USD Million)
  • Table 22 Mexico antibody production market, by type, 2021 - 2033 (USD Million)
  • Table 23 Mexico antibody production market, by end use, 2021 - 2033 (USD Million)
  • Table 24 Europe antibody production market, by country, 2021 - 2033 (USD Million)
  • Table 25 Europe antibody production market, by product, 2021 - 2033 (USD Million)
  • Table 26 Europe antibody production market, by process, 2021 - 2033 (USD Million)
  • Table 27 Europe antibody production market, by type, 2021 - 2033 (USD Million)
  • Table 28 Europe antibody production market, by end use, 2021 - 2033 (USD Million)
  • Table 29 Germany antibody production market, by product, 2021 - 2033 (USD Million)
  • Table 30 Germany antibody production market, by process, 2021 - 2033 (USD Million)
  • Table 31 Germany antibody production market, by type, 2021 - 2033 (USD Million)
  • Table 32 Germany antibody production market, by end use, 2021 - 2033 (USD Million)
  • Table 33 UK antibody production market, by product, 2021 - 2033 (USD Million)
  • Table 34 UK antibody production market, by process, 2021 - 2033 (USD Million)
  • Table 35 UK antibody production market, by type, 2021 - 2033 (USD Million)
  • Table 36 UK antibody production market, by end use, 2021 - 2033 (USD Million)
  • Table 37 France antibody production market, by product, 2021 - 2033 (USD Million)
  • Table 38 France antibody production market, by process, 2021 - 2033 (USD Million)
  • Table 39 France antibody production market, by type, 2021 - 2033 (USD Million)
  • Table 40 France antibody production market, by end use, 2021 - 2033 (USD Million)
  • Table 41 Italy antibody production market, by product, 2021 - 2033 (USD Million)
  • Table 42 Italy antibody production market, by process, 2021 - 2033 (USD Million)
  • Table 43 Italy antibody production market, by type, 2021 - 2033 (USD Million)
  • Table 44 Italy antibody production market, by end use, 2021 - 2033 (USD Million)
  • Table 45 Spain antibody production market, by product, 2021 - 2033 (USD Million)
  • Table 46 Spain antibody production market, by process, 2021 - 2033 (USD Million)
  • Table 47 Spain antibody production market, by type, 2021 - 2033 (USD Million)
  • Table 48 Spain antibody production market, by end use, 2021 - 2033 (USD Million)
  • Table 49 Denmark antibody production market, by product, 2021 - 2033 (USD Million)
  • Table 50 Denmark antibody production market, by process, 2021 - 2033 (USD Million)
  • Table 51 Denmark antibody production market, by type, 2021 - 2033 (USD Million)
  • Table 52 Denmark antibody production market, by end use, 2021 - 2033 (USD Million)
  • Table 53 Sweden antibody production market, by product, 2021 - 2033 (USD Million)
  • Table 54 Sweden antibody production market, by process, 2021 - 2033 (USD Million)
  • Table 55 Sweden antibody production market, by type, 2021 - 2033 (USD Million)
  • Table 56 Sweden antibody production market, by end use, 2021 - 2033 (USD Million)
  • Table 57 Norway antibody production market, by product, 2021 - 2033 (USD Million)
  • Table 58 Norway antibody production market, by process, 2021 - 2033 (USD Million)
  • Table 59 Norway antibody production market, by type, 2021 - 2033 (USD Million)
  • Table 60 Norway antibody production market, by end use, 2021 - 2033 (USD Million)
  • Table 61 Asia Pacific antibody production market, by country, 2021 - 2033 (USD Million)
  • Table 62 Asia Pacific antibody production market, by product, 2021 - 2033 (USD Million)
  • Table 63 Asia Pacific antibody production market, by process, 2021 - 2033 (USD Million)
  • Table 64 Asia Pacific antibody production market, by type, 2021 - 2033 (USD Million)
  • Table 65 Asia Pacific antibody production market, by end use, 2021 - 2033 (USD Million)
  • Table 66 China antibody production market, by product, 2021 - 2033 (USD Million)
  • Table 67 China antibody production market, by process, 2021 - 2033 (USD Million)
  • Table 68 China antibody production market, by type, 2021 - 2033 (USD Million)
  • Table 69 China antibody production market, by end use, 2021 - 2033 (USD Million)
  • Table 70 Japan antibody production market, by product, 2021 - 2033 (USD Million)
  • Table 71 Japan antibody production market, by process, 2021 - 2033 (USD Million)
  • Table 72 Japan antibody production market, by type, 2021 - 2033 (USD Million)
  • Table 73 Japan antibody production market, by end use, 2021 - 2033 (USD Million)
  • Table 74 India antibody production market, by product, 2021 - 2033 (USD Million)
  • Table 75 India antibody production market, by process, 2021 - 2033 (USD Million)
  • Table 76 India antibody production market, by type, 2021 - 2033 (USD Million)
  • Table 77 India antibody production market, by end use, 2021 - 2033 (USD Million)
  • Table 78 South Korea antibody production market, by product, 2021 - 2033 (USD Million)
  • Table 79 South Korea antibody production market, by process, 2021 - 2033 (USD Million)
  • Table 80 South Korea antibody production market, by type, 2021 - 2033 (USD Million)
  • Table 81 South Korea antibody production market, by end use, 2021 - 2033 (USD Million)
  • Table 82 Australia antibody production market, by product, 2021 - 2033 (USD Million)
  • Table 83 Australia antibody production market, by process, 2021 - 2033 (USD Million)
  • Table 84 Australia antibody production market, by type, 2021 - 2033 (USD Million)
  • Table 85 Australia antibody production market, by end use, 2021 - 2033 (USD Million)
  • Table 86 Thailand antibody production market, by product, 2021 - 2033 (USD Million)
  • Table 87 Thailand antibody production market, by process, 2021 - 2033 (USD Million)
  • Table 88 Thailand antibody production market, by type, 2021 - 2033 (USD Million)
  • Table 89 Thailand Antibody production market, by end use, 2021 - 2033 (USD Million)
  • Table 90 Latin America antibody production market, by country, 2021 - 2033 (USD Million)
  • Table 91 Latin America antibody production market, by product, 2021 - 2033 (USD Million)
  • Table 92 Latin America antibody production market, by process, 2021 - 2033 (USD Million)
  • Table 93 Latin America antibody production market, by type, 2021 - 2033 (USD Million)
  • Table 94 Latin America antibody production market, by end use, 2021 - 2033 (USD Million)
  • Table 95 Brazil antibody production market, by product, 2021 - 2033 (USD Million)
  • Table 96 Brazil antibody production market, by process, 2021 - 2033 (USD Million)
  • Table 97 Brazil antibody production market, by type, 2021 - 2033 (USD Million)
  • Table 98 Brazil antibody production market, by end use, 2021 - 2033 (USD Million)
  • Table 99 Argentina antibody production market, by product, 2021 - 2033 (USD Million)
  • Table 100 Argentina antibody production market, by process, 2021 - 2033 (USD Million)
  • Table 101 Argentina antibody production market, by type, 2021 - 2033 (USD Million)
  • Table 102 Argentina antibody production market, by end use, 2021 - 2033 (USD Million)
  • Table 103 Middle East & Africa antibody production market, by product, 2021 - 2033 (USD Million)
  • Table 104 Middle East & Africa antibody production market, by process, 2021 - 2033 (USD Million)
  • Table 105 Middle East & Africa antibody production market, by type, 2021 - 2033 (USD Million)
  • Table 106 Middle East & Africa antibody production market, by end use, 2021 - 2033 (USD Million)
  • Table 107 South Africa antibody production market, by product, 2021 - 2033 (USD Million)
  • Table 108 South Africa antibody production market, by process, 2021 - 2033 (USD Million)
  • Table 109 South Africa antibody production market, by type, 2021 - 2033 (USD Million)
  • Table 110 South Africa antibody production market, by end use, 2021 - 2033 (USD Million)
  • Table 111 Saudi Arabia antibody production market, by product, 2021 - 2033 (USD Million)
  • Table 112 Saudi Arabia antibody production market, by process, 2021 - 2033 (USD Million)
  • Table 113 Saudi Arabia antibody production market, by type, 2021 - 2033 (USD Million)
  • Table 114 Saudi Arabia antibody production market, by end use, 2021 - 2033 (USD Million)
  • Table 115 UAE antibody production market, by product, 2021 - 2033 (USD Million)
  • Table 116 UAE antibody production market, by process, 2021 - 2033 (USD Million)
  • Table 117 UAE antibody production market, by type, 2021 - 2033 (USD Million)
  • Table 118 UAE antibody production market, by end use, 2021 - 2033 (USD Million)
  • Table 119 Kuwait antibody production market, by product, 2021 - 2033 (USD Million)
  • Table 120 Kuwait antibody production market, by process, 2021 - 2033 (USD Million)
  • Table 121 Kuwait antibody production market, by type, 2021 - 2033 (USD Million)
  • Table 122 Kuwait antibody production market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Antibody production market segmentation
  • Fig. 6 Market snapshot, 2024
  • Fig. 7 Market trends & outlook
  • Fig. 8 Market driver relevance analysis (current & future impact)
  • Fig. 9 Market restraint relevance analysis (current & future impact)
  • Fig. 10 PESTEL analysis
  • Fig. 11 Porter's five forces analysis
  • Fig. 12 Global antibody production market: Product movement analysis
  • Fig. 13 Global antibody production market product outlook: Key takeaways
  • Fig. 14 Global antibody production market, for instruments, 2021 - 2033 (USD million)
  • Fig. 15 Global antibody production market, for bioreactors, 2021 - 2033 (USD million)
  • Fig. 16 Global antibody production market, for multi-use bioreactors, 2021 - 2033 (USD million)
  • Fig. 17 Global antibody production market, for single-use bioreactors, 2021 - 2033 (USD million)
  • Fig. 18 Global antibody production market, for chromatography systems, 2021 - 2033 (USD million)
  • Fig. 19 Global antibody production market, for filtration systems, 2021 - 2033 (USD million)
  • Fig. 20 Global antibody production market, for consumables, 2021 - 2033 (USD million)
  • Fig. 21 Global antibody production market, for media, 2021 - 2033 (USD million)
  • Fig. 22 Global antibody production market, for buffers and reagents, 2021 - 2033 (USD million)
  • Fig. 23 Global antibody production market, for chromatography resins and columns, 2021 - 2033 (USD million)
  • Fig. 24 Global antibody production market, for filtration consumables and accessories, 2021 - 2033 (USD million)
  • Fig. 25 Global antibody production market, for others, 2021 - 2033 (USD million)
  • Fig. 26 Global antibody production market, for software, 2021 - 2033 (USD million)
  • Fig. 27 Global antibody production market: Process movement analysis
  • Fig. 28 Global antibody production market process outlook: Key takeaways
  • Fig. 29 Global antibody production market, for upstream processing, 2021 - 2033 (USD million)
  • Fig. 30 Global antibody production market, for downstream processing, 2021 - 2033 (USD million)
  • Fig. 31 Global antibody production market: Type movement analysis
  • Fig. 32 Global antibody production market type outlook: Key takeaways
  • Fig. 33 Global antibody production market, for monoclonal antibody, 2021 - 2033 (USD million)
  • Fig. 34 Global antibody production market, for polyclonal antibody, 2021 - 2033 (USD million)
  • Fig. 35 Global antibody production market: End use movement analysis
  • Fig. 36 Global antibody production end use outlook: Key takeaways
  • Fig. 37 Global Pharmaceutical and biotechnology companies market, 2021 - 2033 (USD Million)
  • Fig. 38 Global research laboratories market, 2021 - 2033 (USD Million)
  • Fig. 39 Global CROs and CDMOs market, 2021 - 2033 (USD Million)
  • Fig. 40 Regional marketplace: key takeaways
  • Fig. 41 Regional outlook, 2021 & 2033
  • Fig. 42 Global antibody production market: region movement analysis
  • Fig. 43 North America antibody production market, 2021 - 2033 (USD million)
  • Fig. 44 U.S. antibody production market, 2021 - 2033 (USD million)
  • Fig. 45 Canada antibody production market, 2021 - 2033 (USD million)
  • Fig. 46 Mexico antibody production market, 2021 - 2033 (USD million)
  • Fig. 47 Europe antibody production market, 2021 - 2033 (USD million)
  • Fig. 48 Germany antibody production market, 2021 - 2033 (USD million)
  • Fig. 49 UK antibody production market, 2021 - 2033 (USD million)
  • Fig. 50 France antibody production market, 2021 - 2033 (USD million)
  • Fig. 51 Italy antibody production market, 2021 - 2033 (USD million)
  • Fig. 52 Spain antibody production market, 2021 - 2033 (USD million)
  • Fig. 53 Denmark antibody production market, 2021 - 2033 (USD million)
  • Fig. 54 Sweden antibody production market, 2021 - 2033 (USD million)
  • Fig. 55 Norway antibody production market, 2021 - 2033 (USD million)
  • Fig. 56 Asia Pacific antibody production market, 2021 - 2033 (USD million)
  • Fig. 57 Japan antibody production market, 2021 - 2033 (USD million)
  • Fig. 58 China antibody production market, 2021 - 2033 (USD million)
  • Fig. 59 India antibody production market, 2021 - 2033 (USD million)
  • Fig. 60 Australia antibody production market, 2021 - 2033 (USD million)
  • Fig. 61 South Korea antibody production market, 2021 - 2033 (USD million)
  • Fig. 62 Thailand antibody production market, 2021 - 2033 (USD million)
  • Fig. 63 Latin America antibody production market, 2021 - 2033 (USD million)
  • Fig. 64 Brazil antibody production market, 2021 - 2033 (USD million)
  • Fig. 65 Argentina antibody production market, 2021 - 2033 (USD million)
  • Fig. 66 Middle East and Africa antibody production market, 2021 - 2033 (USD million)
  • Fig. 67 South Africa antibody production market, 2021 - 2033 (USD million)
  • Fig. 68 Saudi Arabia antibody production market, 2021 - 2033 (USD million)
  • Fig. 69 UAE antibody production market, 2021 - 2033 (USD million)
  • Fig. 70 Kuwait antibody production market, 2021 - 2033 (USD million)